---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-061529"
form_type: "8-K"
ticker: "NEUP"
cik: "0001191070"
company_name: "Neuphoria Therapeutics Inc."
filed_at: "2024-07-16T23:59:59+00:00"
generated_at: "2026-05-31T20:23:54.514842+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Bionomics receives Nasdaq bid price deficiency notice; has until Jan 7, 2025 to regain compliance

## Summary
- Nasdaq notified Bionomics on July 11, 2024 that its ADS bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days (until Jan 7, 2025) to regain compliance by maintaining $1.00 closing bid for 10 consecutive days.
- If not cured by Jan 7, 2025, Bionomics may qualify for a second 180-day period by meeting other listing standards and announcing a reverse stock split plan.
- Failure to cure or qualify for extension could result in delisting from The Nasdaq Global Market.

## SEC filing metadata
- accession: 0001213900-24-061529
- form_type: 8-K
- ticker: NEUP
- cik: 0001191070
- company_name: Neuphoria Therapeutics Inc.
- filed_at: 2024-07-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1191070/000121390024061529/0001213900-24-061529-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1191070/000121390024061529/ea0209330-8k_bionomic.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-061529
- JSON: https://secwatch.observer/filing/0001213900-24-061529.json
- Plain text: https://secwatch.observer/filing/0001213900-24-061529.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.